Migraine drug commonly used in ER may not be best option

October 18, 2017, American Academy of Neurology
Credit: Sasha Wolff/Wikipedia

A drug commonly used in hospital emergency rooms for people with migraine is substantially less effective than an alternate drug and should not be used as a first choice treatment, according to a study published in the October 18, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

"People go to U.S. emergency departments 1.2 million times a year with migraine, and the opioid drug hydromorphone is used in 25 percent of these visits, yet there have been no randomized, high-quality studies on its use for acute migraine," said study author Benjamin W. Friedman, MD, MS, of Albert Einstein College of Medicine in the Bronx, N.Y.

The study found that the drug prochlorperazine, given along with the drug diphenhydramine to prevent the side effect of restlessness, was superior to hydromorphone. Prochlorperazine is a type of drug called a dopamine antagonist. It blocks the release of dopamine, which is one of the many chemical messengers in the brain. The drugs were all given intravenously.

The researchers were also looking at whether the use of an opioid drug led to addiction in some , with return visits to emergency rooms for repeat treatments.

"While this study demonstrates the overwhelming superiority of prochlorperazine over hydromorphone for initial treatment of , the results do not suggest that treatment with IV opioids leads to long-term addiction," Friedman said. "In addition, the results should not be used to avoid the use of opioids for people who have not responded well to anti-dopaminergic drugs."

The study involved 127 people who went to two emergency departments in New York with migraine. Half of the participants received hydromorphone and half received prochlorperazine. The researchers were looking to see how many people had sustained headache relief after 48 hours, which was defined as having a mild headache or no headache two hours after receiving the drug and maintaining that level for 48 hours without needing a rescue medication to stop the migraine.

The study was stopped after 127 people had enrolled because the 48-hour results showed that prochlorperazine was overwhelmingly superior to hydromorphone.

After 48 hours, 37 of the 62 people, or 60 percent, receiving prochlorperazine had sustained headache relief, compared to 20 of the 64 people who received hydromorphone, or 31 percent. In the emergency room, 31 percent of those who received hydromorphone asked for a second dose of the , compared to 8 percent of those who received prochlorperazine. Of those receiving , 36 percent requested other pain-reliever drugs, compared to 6 percent of the other group.

There was no difference between the two groups in how often they returned to the ER for within one month of the treatment.

Friedman said that one limitation of the study is that participants were required to have not used opioids during the previous month and to have no history of addiction to prescription or illicit opioids, so the participants may have been at lower risk for problems with use than the general population.

Explore further: New drug to prevent migraine may start working in days

Related Stories

New drug to prevent migraine may start working in days

June 8, 2016
A new drug to prevent migraine was associated with fewer headache hours for people with chronic migraine within three to seven days after the first injection, according to a study published in the June 8, 2016, online issue ...

First-in-class nasal spray demonstrates promise for migraine pain relief

November 6, 2014
Researchers are developing a novel prochlorperazine nasal spray formulation as a potential new treatment for migraines. This work is being presented at the 2014 American Association of Pharmaceutical Scientists (AAPS) Annual ...

Opioids overused in migraine treatment, regardless of race, study finds

August 17, 2017
African-Americans are more likely to experience debilitating migraine headaches than whites, but a new study probing the issue found no evidence of racial disparities in treatment practices.

Methadone may reduce need for opioids after surgery

April 24, 2017
Patients undergoing spinal fusion surgery who are treated with methadone during the procedure require significantly less intravenous and oral opioids to manage postoperative pain, reports a new study published in the May ...

Wireless arm patch may blunt migraine pain

March 1, 2017
A wireless arm patch may be a promising new treatment for migraine headaches, researchers report.

New drugs offer hope for migraine prevention

April 22, 2014
Two new studies may offer hope for people with migraine. The two studies released today will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014.

Recommended for you

Automated detection of focal epileptic seizures in a sentinel area of the human brain

August 17, 2018
Patients with focal epilepsy that does not respond to medications badly need alternative treatments.

People are more honest when using a foreign tongue, research finds

August 17, 2018
New UChicago-led research suggests that someone who speaks in a foreign language is probably more credible than the average native speaker.

CRISPR technology targets mood-boosting receptors in brain

August 17, 2018
An estimated 13 percent of Americans take antidepressant drugs for depression, anxiety, chronic pain or sleep problems. For the 14 million Americans who have clinical depression, roughly one third don't find relief with antidepressants.

Critical role of DHA on foetal brain development revealed

August 17, 2018
Duke-NUS researchers have found evidence that a natural form of Docosahexaenoic Acid (DHA) made by the liver called Lyso-Phosphatidyl-Choline (LPC-DHA), is critical for normal foetal and infant brain development, and that ...

Brain response study upends thinking about why practice speeds up motor reaction times

August 16, 2018
Researchers in the Department of Physical Medicine and Rehabilitation at Johns Hopkins Medicine report that a computerized study of 36 healthy adult volunteers asked to repeat the same movement over and over became significantly ...

Men and women show surprising differences in seeing motion

August 16, 2018
Researchers reporting in the journal Current Biology on August 16 have found an unexpected difference between men and women. On average, their studies show, men pick up on visual motion significantly faster than women do.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.